Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling - Luo_2023_J.Transl.Med_21_71 |
| Author(s) : Luo A , Wu Z , Li S , McReynolds CB , Wang D , Liu H , Huang C , He T , Zhang X , Wang Y , Liu C , Hammock BD , Hashimoto K , Yang C |
| Ref : J Transl Med , 21 :71 , 2023 |
| Abstract : Luo_2023_J.Transl.Med_21_71 |
| ESTHER : Luo_2023_J.Transl.Med_21_71 |
| PubMedSearch : Luo_2023_J.Transl.Med_21_71 |
| PubMedID: 36732752 |
| Title : sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury - Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119 |
| Author(s) : Bergmann CB , McReynolds CB , Wan D , Singh N , Goetzman H , Caldwell CC , Supp DM , Hammock BD |
| Ref : Proc Natl Acad Sci U S A , 119 :e2120691119 , 2022 |
| Abstract : Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119 |
| ESTHER : Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119 |
| PubMedSearch : Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119 |
| PubMedID: 35312372 |
| Title : Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development - McReynolds_2021_Molecules_26_ |
| Author(s) : McReynolds CB , Yang J , Guedes A , Morisseau C , Garcia R , Knych H , Tearney C , Hamamoto B , Hwang SH , Wagner K , Hammock BD |
| Ref : Molecules , 26 : , 2021 |
| Abstract : McReynolds_2021_Molecules_26_ |
| ESTHER : McReynolds_2021_Molecules_26_ |
| PubMedSearch : McReynolds_2021_Molecules_26_ |
| PubMedID: 34443621 |
| Title : Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections - McReynolds_2021_Front.Physiol_12_663869 |
| Author(s) : McReynolds CB , Cortes-Puch I , Ravindran R , Khan IH , Hammock BG , Shih PB , Hammock BD , Yang J |
| Ref : Front Physiol , 12 :663869 , 2021 |
| Abstract : McReynolds_2021_Front.Physiol_12_663869 |
| ESTHER : McReynolds_2021_Front.Physiol_12_663869 |
| PubMedSearch : McReynolds_2021_Front.Physiol_12_663869 |
| PubMedID: 33868029 |
| Title : Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative - Hammock_2021_J.Med.Chem__ |
| Author(s) : Hammock BD , McReynolds CB , Wagner K , Buckpitt A , Cortes-Puch I , Croston G , Lee KSS , Yang J , Schmidt WK , Hwang SH |
| Ref : Journal of Medicinal Chemistry , : , 2021 |
| Abstract : Hammock_2021_J.Med.Chem__ |
| ESTHER : Hammock_2021_J.Med.Chem__ |
| PubMedSearch : Hammock_2021_J.Med.Chem__ |
| PubMedID: 33550801 |
| Title : Development of Improved Double Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in PBMCs of Diabetic and Pre-frontal Cortex of Multiple Sclerosis Patients - Li_2020_Anal.Chem_92_7334 |
| Author(s) : Li D , Morisseau C , McReynolds CB , Duflot T , Bellien J , Nagra RM , Taha AY , Hammock BD |
| Ref : Analytical Chemistry , 92 :7334 , 2020 |
| Abstract : Li_2020_Anal.Chem_92_7334 |
| ESTHER : Li_2020_Anal.Chem_92_7334 |
| PubMedSearch : Li_2020_Anal.Chem_92_7334 |
| PubMedID: 32253910 |
| Title : Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain - Wagner_2020_Neurotherapeutics_17_900 |
| Author(s) : Wagner KM , Gomes A , McReynolds CB , Hammock BD |
| Ref : Neurotherapeutics , 17 :900 , 2020 |
| Abstract : Wagner_2020_Neurotherapeutics_17_900 |
| ESTHER : Wagner_2020_Neurotherapeutics_17_900 |
| PubMedSearch : Wagner_2020_Neurotherapeutics_17_900 |
| PubMedID: 32875445 |
| Title : Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis - McReynolds_2019_Front.Pharmacol_10_533 |
| Author(s) : McReynolds CB , Hwang SH , Yang J , Wan D , Wagner K , Morisseau C , Li D , Schmidt WK , Hammock BD |
| Ref : Front Pharmacol , 10 :533 , 2019 |
| Abstract : McReynolds_2019_Front.Pharmacol_10_533 |
| ESTHER : McReynolds_2019_Front.Pharmacol_10_533 |
| PubMedSearch : McReynolds_2019_Front.Pharmacol_10_533 |
| PubMedID: 31214021 |
| Title : In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea - Wan_2019_Front.Pharmacol_10_464 |
| Author(s) : Wan D , Yang J , McReynolds CB , Barnych B , Wagner KM , Morisseau C , Hwang SH , Sun J , Blocher R , Hammock BD |
| Ref : Front Pharmacol , 10 :464 , 2019 |
| Abstract : Wan_2019_Front.Pharmacol_10_464 |
| ESTHER : Wan_2019_Front.Pharmacol_10_464 |
| PubMedSearch : Wan_2019_Front.Pharmacol_10_464 |
| PubMedID: 31143115 |
| Title : Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases - Wagner_2017_Pharmacol.Ther_180_62 |
| Author(s) : Wagner KM , McReynolds CB , Schmidt WK , Hammock BD |
| Ref : Pharmacol Ther , 180 :62 , 2017 |
| Abstract : Wagner_2017_Pharmacol.Ther_180_62 |
| ESTHER : Wagner_2017_Pharmacol.Ther_180_62 |
| PubMedSearch : Wagner_2017_Pharmacol.Ther_180_62 |
| PubMedID: 28642117 |